Defects in microcirculation have been documented as major factors in the development of cardiovascular diseases, especially type 1 diabetes. By treating microcirculation defects, thus increasing blood and oxygen flow to the heart, the risk of recurrent significant cardiovascular events can be reduced significantly, and strength and endurance can improve.
An example of microcirculation compromise in a patient with severe cardiovascular disease can be seen in the clinical case of Leo B.
Leo was a 64-year-old male with a medical history of diabetes mellitus for 15 years, cigarette smoking, elevated cholesterol, and high LDL (harmful blood fat) levels.
Leo had a heart attack (myocardial infarction) several years ago.
He had suffered a myocardial infarction 6 weeks earlier and also suffered from exertional angina (chest pain with exertion).
He was taking lisinopril (20 mg per day) for high blood pressure, insulin for his diabetes, and one baby aspirin a day as a blood thinner to prevent another heart attack.
Leo was put on a cardiac rehabilitation regimen consisting of a low-fat diet, moderate exercise, and stress control.
He used D’OXYVAas an adjunct application, which helped increase his strength and endurance while decreasing his episodes of exertional chest pain.
What is Microcirculation?
In general, microcirculation refers to the smallest blood vessels in the body, consisting of the arterioles, venules, and capillaries.
These tiny blood vessels supply oxygen to the organs of the body and remove waste products produced by the body’s metabolism.
Smooth muscle cells, which are the lining cells of the arterioles and of some venules, are under the control of the sympathetic and parasympathetic nervous systems and other chemical factors.
These influences help control the ability of the microcirculatory system to dilate and contract to increase or decrease circulation and oxygenation.
YOU MAY ALSO LIKE
- Apple Watch 4 can detect D’OXYVA’s benefits
- Researchers Identify Underlying Main Causes of Brain Damage, Dementia and Potential Breakthrough Solution (Part I)
- Award-winning documentary hosted by actor Dennis Quaid invites Circularity to talk about D’OXYVA
What is Coronary Microcirculation?
Coronary microcirculation (microvascular network) refers to the smallest arterioles and venules that supply the heart.
These tiny branching blood vessels play crucial roles in supplying oxygen and removing waste products from the heart muscle.
When the heart requires more oxygen, the arterioles dilate, increasing blood flow to the heart.
This is especially important if a patient suffers from cardiovascular conditions such as angina or heart failure.
What Causes Cardiac Microcirculation Dysfunction?
Dysfunction of cardiac microcirculation can be caused by many factors, including:
- Dysfunction of the endothelial (lining) cells of the arterioles, which affects the ability of arterioles to dilate and allow for increased blood flow
- Increased alpha 2 adrenergic activity, which leads to vasoconstriction and resultant decreased cardiac perfusion
- Sclerosing of the arterioles, causing reduced blood flow and oxygenation
Microcirculation consists of the smallest blood vessels in the body and includes cardiac microcirculation, which plays a crucial role in supplying oxygen and removing waste products from the heart. The transdermal deoxyhemoglobin vasodilator D’OXYVA plays an important role in increasing blood flow (perfusion) and resultant oxygenation to the cardiovascular system. This increase in oxygenation has been found to help increase endurance and strength and is an important adjunct solution to consider as part of cardiac rehabilitation.
HOW D’OXYVA CAN HELP?
D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory solution that has been validated to significantly improve microcirculation.
The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.